Cervical cancer is preventable, but still a leading cancer

January 11, 2017 by Dr. Rachel Miller
High grade dysplasia (carcinoma in situ) in the uterine cervix. The abnormal epithelium is extending into a mucus gland to the left of centre. This disease can progress to invasive cancer (squamous cell carcinoma) of the cervix. Credit: Haymanj/public domain

At the beginning of the year, many women (and men) set resolutions around health and fitness, often focusing on weight loss. But one of the most important habits women can form revolves around regular health checks, particularly for preventable cancers.

January is cervical cancer awareness month. Unfortunately, Kentucky ranks in the top 10 in the country for cervical cancer incidence and death rates – a dire statistic considering cervical cancer is largely preventable through vaccination and screening.

The human papillomavirus (HPV) causes virtually all cases of cervical carcinomas. The majority of sexually active women will be exposed to HPV at some point in their lifetime; fortunately, only 5 to 15 percent will develop cervical precancer. An even smaller percentage will develop cancer. Other risk factors include multiple pregnancies, a long duration of use, a history of other STDs, and tobacco use.

Nowadays, you can take an extra step toward protecting your children against cervical and other types of HPV-related cancers through the HPV vaccine. While this vaccination used to be a three-dose process, the CDC now recommends that all 11-12 year-old children (girls AND boys) get just two doses, with the second being given 6-12 months after the first.

Young women can get the vaccine through age 26, while young men can get vaccinated through age 21. Every year, more than 17,000 women and more than 9,000 men get cancer caused by an HPV infection.

Cervical cancer screening – the Pap smear – is a regular appointment that is often overlooked. This test looks for cancerous cells on the cervix, and can even find precancerous changes that have not yet developed into cancer.

I can't recommend this test enough – at Markey, about 95 percent of cervical cancer patients we treat have not gotten their recommended schedule of cervical cancer screenings. Screenings usually begin at age 21 or three years after first sexual intercourse. Talk to your doctor about a timeline for regular screenings.

One reason the vaccine and screenings are so important is because often doesn't cause obvious symptoms until its more advanced stages.

Some of the most common symptoms reported include abnormal bleeding or bleeding after , and an abnormal discharge. Many of these symptoms can be mistaken for less serious issues, such as a yeast infection or .

As the cancer advances further, it can cause urinary blockage, back pain, leg swelling, or neuropathic pain, such as a "pins and needles" sensation in the skin.

As you work through your resolutions for the New Year, make taking care of yourself a priority—and that includes scheduling a few regular trips to your doctor.

Explore further: Cervical cancer screening could be less frequent, start later

Related Stories

Cervical cancer screening could be less frequent, start later

October 17, 2016
Women may only need cervical cancer screening every 5-10 years—instead of every three years, as currently recommended—and may be able to start the screenings later in life, according to a new study from Harvard T.H. Chan ...

More than two-thirds of cervical cancer deaths prevented by screening

September 19, 2016
Cervical screening prevents 70 per cent of cervical cancer deaths and if all eligible women regularly attended screening this would rise to 83 per cent, according to research led by Queen Mary University of London (QMUL).

Routine screenings prevent cervical cancer in elderly women

July 7, 2016
A new study from the University of Illinois confirms a link between routine Pap smear screenings and a lower risk of developing cervical cancer in women over age 65. However, most American health guidelines discourage women ...

HPV vaccine reduced cervical abnormalities in young women

July 4, 2016
Young women who received the human papillomavirus (HPV) vaccine through a school-based program had fewer cervical cell anomalies when screened for cervical cancer, found a new study in CMAJ (Canadian Medical Association Journal).

New research shows HPV vaccine reduces cervical pre-cancers in young women

September 29, 2016
Every 20 minutes, someone in the United States receives a cancer diagnosis related to human papillomavirus. HPV causes cancer of the cervix, anus and throat. The HPV vaccine can prevent infections causing most of these kinds ...

Low incidence of cervical cancer, CIN3+ for HPV-negative women

October 7, 2016
(HealthDay)—Human papillomavirus (HPV)-negative women have low long-term incidence of cervical cancer and cervical intraepithelial neoplasia (CIN) grade 3 or worse (CIN3+), which supports an extension of the cervical screening ...

Recommended for you

Clinical trial suggests new cell therapy for relapsed leukemia patients

November 20, 2017
A significant proportion of children and young adults with treatment-resistant B-cell leukemia who participated in a small study achieved remission with the help of a new form of gene therapy, according to researchers at ...

Researchers discover a new target for 'triple-negative' breast cancer

November 20, 2017
So-called "triple-negative" breast cancer is a particularly aggressive and difficult-to-treat form. It accounts for only about 10 percent of breast cancer cases, but is responsible for about 25 percent of breast cancer fatalities.

Study reveals new mechanism used by cancer cells to disarm attacking immune cells

November 20, 2017
A new study by researchers at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute (OSUCCC - James) identifies a substance released by pancreatic cancer cells that protects ...

Cell-weighing method could help doctors choose cancer drugs

November 20, 2017
Doctors have many drugs available to treat multiple myeloma, a type of blood cancer. However, there is no way to predict, by genetic markers or other means, how a patient will respond to a particular drug. This can lead to ...

Lung cancer triggers pulmonary hypertension

November 17, 2017
Shortness of breath and respiratory distress often increase the suffering of advanced-stage lung cancer patients. These symptoms can be triggered by pulmonary hypertension, as scientists at the Max Planck Institute for Heart ...

Researchers discover an Achilles heel in a lethal leukemia

November 16, 2017
Researchers have discovered how a linkage between two proteins in acute myeloid leukemia enables cancer cells to resist chemotherapy and showed that disrupting the linkage could render the cells vulnerable to treatment. St. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.